- 75$14.9M
1
- 102$34.4M
2
- 321<$5M
3
- 84$17.1M
4
- 62$5.1M
5
- 107$22.6M
6
Kriya Therapeutics
Business Services · California, United States · 160 Employees
Kriya Therapeutics is a fully integrated company pioneering novel technologies and therapeutics in gene therapy. The company aims to revolutionize how gene therapies are designed, developed, and manufactured - improving speed to market and delivering significant reductions in cost per dose. Kriya is built on two distinct technology platforms: its computationally enabled proprietary platform for rational vector design (SIRVE™) and its innovative high-efficiency manufacturing platform for scalable and low-cost production (STRIPE™). The company is advancing a deep and diversified pipeline of innovative gene therapies spanning rare and prevalent diseases in multiple therapeutic verticals, with current pipeline programs in ophthalmology, oncology, and metabolic disease. With locations in Silicon Valley, Calif., and Research Triangle Park, N.C., Kriya was founded by pioneers in the biopharmaceutical industry and is backed by blue-chip life sciences and technology investors.Read More
View Company Info for Free
Who is Kriya Therapeutics
Headquarters
Phone Number
Website
Revenue
Industry
Top Competitors of Kriya Therapeutics
Kriya Therapeutics Org Chart
Kriya Therapeutics Company Metrics
$610.5M
Total Funding Amount
$430M
Most Recent Funding Amount
3
Number of Funding Rounds
Aug 22, 2020
Redpin Therapeutics
See More Acquisitions & Subsidiaries
Kriya Therapeutics Tech Stack
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Kriya Therapeutics News & Media
Fresh off raising $150M, Durham gene therapy startup Kriya acquires Spain-based company
Kriya Therapeutics Inc., with dual headquarters in Durham and Palo Alto, Calif., has acquired a gene therapy startup that Kriya says will align with its approach to treating metabolic disease.Gene Therapy Developer Kriya Therapeutics Raises Additional $150M in Series C Financing
The additional capital brings the total raised in the round to more than $430 million, which the firm will use to advance its pipeline.Kriya to Present 10 Abstracts at the 2023 American Society of Gene and Cell Therapy Annual Meeting
PALO ALTO, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya announced that it will present 10 abstracts at ASGCT 2023.Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., today announced the acquisition of Redpin Therapeutics, Inc.
Frequently Asked Questions regarding Kriya Therapeutics
Kriya Therapeutics is a fully integrated company pioneering novel technologies and therapeutics in gene therapy. The company aims to revolutionize how gene therapies are designed, developed, and manufactured - improving speed to market and delivering significant reductions in cost per dose. Kriya is built on two distinct technology platforms: its c... Read More